MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Boston Scientific settles Cordis stent war for $716 million

Boston Scientific settles Cordis stent war for $716 million

By

Boston Scientific Corp. agreed to shell out $716 million to settle 14 patent infringement suits with Cordis Corp., closing a major front in the stent wars.

The Natick, Mass.-based medical device giant said it will pay the settlement in cash using a reserve set aside for one of the lawsuits.

The suits aren’t the only cases pending between BSX and Cordis parent Johnson & Johnson, but president and CEO Ray Elliott said Boston Scientific will continue to work on resolving the others.

The settled cases, involving lawsuits in U.S., Canadian, Belgian, German, French and Italian courts, include the so-called Palmaz-NIR suit, involving a patent by the radiologist who invented stents, Julio Palmaz.

The estimated settlement cost in that case would make up most of the $716 million nut to settle it and the other 13 suits.

Johnson & Johnson owns that patent and in 2000 won a lawsuit alleging that an early BoSci stent, the NIR, infringed the technology, according to the Wall Street Journal (paid). Boston Scientific appealed, but told investors last year that it expected that case to cost at least $703 million.

At least three other lawsuits between the stent colossi still have a pulse, including a Cordis suit over Boston Scientific’s Express, Taxus, Taxus Liberté, Promus and NIR stents and a Boston Scientific suit over Cordis’ Cypher drug-eluting stent.

The announcement is not the first big-ticket settlement between medical device leviathans. In July, Medtronic paid $444 million to arch-rival Abbott to settle a stent patent lawsuit.

Here’s a complete list of the cases in the latest settlement:

  1. Cordis Corp. v. Medtronic Vascular Inc., Boston Scientific Corp. et al.
  2. Johnson & Johnson Inc., Expandable Grafts Partnership & Cordis Corp. v. Boston Scientific Ltd./Boston Scientifique LTEE
  3. Johnson & Johnson Inc. v. Boston Scientific Ltd./Boston Scientifique LTEE
  4. Boston Scientific Corp. v. Johnson & Johnson
  5. Schneider (Europe) GmbH v. Johnson & Johnson Medical NV
  6. Schneider (Europe) GmbH v. Cordis Medizinische Apparate GmbH
  7. Schneider (Europe) GmbH v. Cordis
  8. Schneider (Europe) GmbH v. Johnson & Johnson Medical S.P.A.
  9. Cordis v. Schneider (damage request)
  10. Boston Scientific Scimed Inc. v. Cordis Corp.
  11. Boston Scientific Scimed Inc. v. Cordis Medizinische Apparate GmbH
  12. Boston Scientific Scimed Inc. v. Cordis Medizinische Apparate GmbH
  13. Scimed Life Systems Inc. v. Cordis Corp.
  14. Cordis Corp. v. Scimed Life Systems Inc.

In case you missed it

RSS From Medical Design & Outsourcing

  • November 2021 Issue: The Big 100 – Medtech’s 100 Largest Players
      Browse the online version of the Big 100 An even larger medtech supply chain shock looms beyond the pandemic European approval ‘a big deal’ as Medtronic moves forward with Hugo surgical robot How medtech fared in the first waves of the pandemic People move the medtech industry forward The term “supply chain” brings to… […]
  • Could winged microchips monitor for airborne disease?
    Northwestern University engineers have created what they claim are the smallest-ever human-made flying structures — winged microchips that could monitor the air for disease and pollution. Engineering professor John Rogers and his team at Northwestern drew on inspiration from nature to create the microchips, which are the size of a grain of sand. The chips… […]
  • Smith+Nephew expands reach of its Cori handheld robotic system
    A year after Smith+Nephew (NYSE:SNN) launched its Cori handheld robotic system in the U.S.,  the ortho surgery system has launched globally. The British medtech giant has expanded Cori’s reach to Europe, Australia and New Zealand, India, and Canada (just announced today). The company yesterday said the system was now available for use in the U.K.’s National Health… […]
  • Elizabeth Holmes reportedly expresses remorse in criminal fraud trial
    Elizabeth Holmes reportedly revealed some regret over her handling of business as the ex-Theranos CEO took the stand again in a criminal fraud trial. Taking the stand yesterday for the third day of testimony in federal court in San Jose, California, Holmes was said to have shown remorse while still shifting some of the blame… […]
  • Supply chain, manufacturing issues slow Medtronic’s Hugo launch, ramp-up expected next fiscal year
    Medtronic (NYSE:MDT) Chair & CEO Geoff Martha confirmed that the launch of the Hugo surgical robot platform is off-schedule. Hugo received CE mark approval last month. The company is gearing up to conduct its FDA investigational device exemption (IDE) clinical trials in the U.S., with more on its stateside efforts still to come, Medtronic’s surgical robotics… […]
  • Minnetronix Medical honored in Minnesota for its MindsEye Expandable Port
    Minnetronix Medical (St. Paul, Minn.) received an award from the Minnesota Technology Association that highlights its MindsEye Expandable Port for minimally invasive deep brain access. The company won the association’s TEKNE award for best medical technology and devices. “Given Minnesota is a global epicenter for the medical device industry, this award is quite meaningful to Minnetronix… […]
  • BD expands biosciences business with reagent innovation center in San Diego
    A life sciences real estate developer announced today that BD (NYSE:BDX) selected its property as a new facility for its biosciences business. Through a joint venture with Tishman Speyer and Bellco Capital, Breakthrough Properties confirmed that BD chose its Torrey View by Breakthrough property for an expanded San Diego reagent innovation center within its biosciences… […]
  • The best places to work for medtech sales reps in 2022
    Teleflex (NYSE:TFX), ConMed (NSDQ:CNMD) and Medtronic (NYSE:MDT) topped the list of best places to work in medtech sales in 2022, according to a MedReps.com survey of medical sales representatives. The 11th annual MedReps survey polled over 2,300 MedReps professionals to determine which medtech sales companies are most sought-after in the industry. Overall, pay and leadership were the most… […]
  • How medtech fared in the first waves of the pandemic
    Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data. Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying… […]
  • FreeStyle Libre 3, other Abbott products recognized at CES Innovation Awards
    Abbott (NYSE:ABT) was honored for a handful of its offerings at the Consumer Electronics Show (CES) 2022 Innovation Awards. The company’s FreeStyle Libre 3 continuous glucose monitoring (CGM) system ranked among the top 15 products in the CES Best of Innovation category. The next-generation CGM system features the world’s smallest, thinnest glucose sensor that can… […]
  • Evonik launches new Resomer PrintPowder polymers for 3D printing of personalized, implantable medical devices
    Evonik has launched the second generation of Resomer PrintPowder polymers for 3D printing of personalized, implantable medical devices. Essen, Germany-based Evokik said the powders have a broader range of customizable mechanical properties and degradation rates, allowing their use for more complex and tailored medical devices including orthopedic, dental, or soft tissue applications. “These new powders… […]

Leave a Reply